“RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY”. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases 31, no. 1 (March 1, 2024): 394–406. Accessed May 18, 2024. https://jrdiabet.ro/index.php/RJDNMD/article/view/307.